Navigation Links
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Date:12/23/2009

ely $380 million) and its market share was about 12%.

About Dyslipidemia and Hypercholesterolemia

Dyslipidemia refers to abnormal levels of fatty substances in the blood, or a disorder of the production or breakdown process of lipoprotein. Dyslipidemia may be marked by an elevation of total cholesterol, LDL-C, and triglyceride (TG) concentrations and a decrease in HDL-C in the blood. An elevated level of cholesterol in the blood is called hypercholesterolemia, commonly referred to as high cholesterol.

LDL-C lowering is well established as one of the strongest independent predictors of cardiovascular morbidity and mortality. Despite the availability of treatments in the U.S., there is still a need for better control of and treatment for dyslipidemia. According to the American Heart Association, approximately one out of every three American adults has an LDL cholesterol level of 130mg/dL or higher, which is a major risk factor for coronary heart disease (CHD) and stroke. In addition, less than half of patients who qualify for any kind of lipid-modifying treatment for CHD risk reduction are receiving it, and only about one-third of patients who are on treatment are achieving their LDL goals.

IMPORTANT SAFETY INFORMATION ABOUT LIVALO® (PITAVASTATIN) TABLETS

INDICATIONS AND USAGE

Drug therapy should be one component of multiple-risk-factor intervention in individuals who require modifications of their lipid profile. Lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol only when the response to diet and other nonpharmacological measures has been inadequate.

LIVALO is a HMG-CoA reductase inhibitor indicated as an adjunctive therapy to diet to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase HDL-C in adult patients with
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 2014 GenomeDx Biosciences today announced data ... Society for Radiation Oncology (ASTRO) Annual Meeting demonstrate ... a genomic test capable of predicting aggressiveness of ... patient outcomes for prostate cancer patients following surgery. ... published study that demonstrates how Decipher test results ...
(Date:9/15/2014)... -- Patients in today,s changing health care landscape are receiving ... setting versus a hospital. In an effort to stay ... continue to receive high quality medical care; Kaiser Permanente ... medicine residency program. The program,s progressive curriculum will prepare ... even virtual settings. "We are excited ...
(Date:9/15/2014)... N.J. , Sept. 15, 2014 /PRNewswire-iReach/ -- ... , University of South Carolina, submitted a Citizen ... Commissioner, asking the FDA to add another Black ... drug labels.  This request asks for a Black ... "toxic psychoses, hallucinations, paranoia, suicidal thoughts or acts, ...
Breaking Medicine Technology:Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 3Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 2Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 3Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3
... PARSIPPANY, N.J., March 31, 2011 Pacira Pharmaceuticals, Inc. ... company, today announced financial results for the fourth quarter ... on the execution of its pre-commercial and launch strategies ... "Since our initial public offering in February, we have ...
... CardioNexus Corporation ( www.cardionexus.com ) an affiliated ... Panasonic CardioHealth® Station at the 2011 Annual Scientific ... device, which has just received clearance from the ... and portable cardiovascular imaging device which aims to ...
Cached Medicine Technology:Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 2Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 3Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 4Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 5Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 6Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 7Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 8Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 9Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results 10Breakthrough CardioHealth® Station Cleared By FDA to Take Center Stage at the Annual Scientific Sessions of the American College of Cardiology 2011 2Breakthrough CardioHealth® Station Cleared By FDA to Take Center Stage at the Annual Scientific Sessions of the American College of Cardiology 2011 3Breakthrough CardioHealth® Station Cleared By FDA to Take Center Stage at the Annual Scientific Sessions of the American College of Cardiology 2011 4
(Date:9/16/2014)... (PRWEB) September 16, 2014 The rapidly ... concern for health plans, employers and PBMs as spending ... of their drug lists. Once a concentrated, patient-specific practice, ... 25 webinar from Atlantic Information Services, Inc. (AIS), ... will offer details of what one leading health ...
(Date:9/16/2014)... San Diego, CA (PRWEB) September 16, 2014 ... a new hydrating lip gloss that true-ly pampers lips from ... your lips satin-smooth all day. , “The creation of true ... were suffering from dry, dehydrated lips no matter what products ... that not only looked great on, but could actually hydrate ...
(Date:9/16/2014)... Triad Semiconductor, Inc. today announced that David ... former President of Linear Technology Corporation was appointed to ... technology and business expertise, and we are delighted that ... Hayden, Triad CEO and chairman. , Mr. Bell brings ... semiconductor experience to Triad's board. From 2008 to 2012, ...
(Date:9/15/2014)... St. Louis, Missouri (PRWEB) September 16, 2014 ... injury lawyers at Carey Danis & Lowe ... Boston Scientific Corp., was found responsible for the injuries ... their bladder sling to treat stress urinary incontinence (SUI). ... that practices defective medical device litigation and personal injury ...
(Date:9/15/2014)... 2014 iFitDress.com, one of the most distinguished ... sapphire evening dresses to its online store. In ... top quality products. They are now provided at very low ... senior spokesman has confidence in the newly unveiled sapphire evening ... by customers from all over the world. Up to now, ...
Breaking Medicine News(10 mins):Health News:Sept. 25 Webinar to Offer Health Plan, Employer Strategies to Control Compounded Medication Costs 2Health News:True Science Cosmetics, LLC Launches True Lipz™ 2Health News:David Bell Joins Triad Semiconductor's Board of Directors 2Health News:Carey Danis & Lowe Reports On $73 Million Boston Scientific Verdict 2Health News:Beautiful Sapphire Evening Dresses Provided By iFitDress.com 2
... trial finds better control of disease when chemo is targeted ... News) -- The number one cancer killer, lung cancer, may ... drugs to tumors with key genetic traits, a new study ... -- found that, overall, 46 percent of patients with stage ...
... ... successfully completed deployment of CellTrak workflow automation and visit compliance solutions. The result ... ... 18, 2010 -- ABC Hospice, Inc, a premier hospice provider in North East Alabama, ...
... , ... Touchstone Products LLC is proud to announce ... quality Infrared Saunas at affordable prices directly to the American Consumer. ... in the privacy of your home. Constructed from the highest ...
... ... in Trilogy Analytical Laboratory , ... Darmstadt, Germany (PRWEB) April 17, 2010 -- R-Biopharm AG, a leading developer ... that the company has purchased a majority ownership position in Trilogy Analytical Laboratory, Inc. ...
... along the U.S.-Mexico border frequently buy over-the-counter oral contraceptives ... and can send a friend to pick up the ... University of Texas campuses and Ibis Reproductive Health. ... there is demand in the United States for over-the-counter ...
... is available in French . , "It is high ... and help people who suffer from this disease," says Dr. Jean ... the Montreal Chest Institute of the MUHC, and lead investigator of ... Centre for Cardiovascular and Pulmonary Research, University of British Columbia. As ...
Cached Medicine News:Health News:Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes 2Health News:Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes 3Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 2Health News:CellTrak Increases Employee Productivity and Efficiencies at ABC Hospice, Inc. 3Health News:Touchstone Saunas Goes Online to Provide Premium Quality Infrared Saunas 2Health News:R-Biopharm Group Purchases a Majority Ownership in Trilogy Lab, Expanding US Operations 2Health News:Convenience drives US women to buy over-the-counter contraception in Mexico, study finds 2Health News:MUHC leads pan-Canadian initiative on respiratory disease 2
... custom bars have a large body ... contacts (spaced 3 centimeters center-to-center) to ... repeated cleaning. Polarity indicators are molded ... handle fits our bar electrode styles. ...
... phakic IOL is the first lens of its ... for the reduction or elimination of myopia in ... diopters and in patients aged 21 and over. ... 150,000 procedures performed worldwide, results prove that the ...
... the strongest vacuum force in ... The unit includes a ... plug, footswitch, built-in wheels, retractable ... ring to hold the liquid ...
... technology for the phakic eye, clinically ... quality of vision and visual acuity ... lens is compatible with current cataract ... for the correction of myopia in ...
Medicine Products: